Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 375 of 441 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/31/09
End: 02/29/12
Due: 02/28/13
Phase: N/A
Priority: Normal
Start: 12/31/09
End: 10/31/11
Due: 10/31/12
Phase: N/A
Priority: Normal
Start: 07/31/04
End: 09/20/06
Due: 09/20/07
Phase: N/A
Priority: Normal
Start: 08/31/03
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 05/01/23
End: 07/01/27
Due: 07/01/28
Phase: N/A
Priority: Normal
Start: 12/29/17
End: 11/28/20
Due: 11/28/21
Phase: N/A
Priority: Normal
Start: 05/31/07
End: 05/31/08
Due: 05/31/09
Phase: N/A
Priority: Normal
Start: 11/02/22
End: 09/30/24
Due: 09/30/25
Phase: N/A
Priority: Normal
Start: 02/28/03
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 11/30/14
End: 10/31/17
Due: 10/31/18
Phase: N/A
Priority: Normal
Start: 01/31/24
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 01/25/22
End: 03/31/24
Due: 03/31/25
Phase: N/A
Priority: Normal
Start: 01/09/23
End: 06/30/24
Due: 06/30/25
Phase: N/A
Priority: Normal
Start: 08/31/25
End: 07/31/28
Due: 07/31/29
Phase: N/A
Priority: Normal
Start: 12/31/08
End: 01/31/16
Due: 01/31/17
Accuracy of Dilution of EUS-FNA Pancreatic Cyst Fluid for Carcinoembryonic Antigen (CEA) Measurement
Phase: N/A
Priority: Normal
Start: 04/30/11
End: 07/31/12
Due: 07/31/13
Phase: N/A
Priority: Normal
Start: 07/31/03
End: 09/30/10
Due: 09/30/11
Phase: N/A
Priority: Normal
Start: 02/03/24
End: 10/31/30
Due: 10/31/31
Phase: N/A
Priority: Normal
Start: 04/30/14
End: 02/28/19
Due: 02/28/20
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 07/03/17
Due: 07/03/18
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/11
End: 08/31/26
Due: 08/31/27
Phase: N/A
Priority: Normal
Start: 08/31/24
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 12/31/11
End: 12/31/11
Due: 12/31/12
Phase: N/A
Priority: Normal
Start: 10/31/05
End: 09/04/13
Due: 09/04/14